4-iodo-2,5-dimethoxyphenylisopropylamine has been researched along with Action Tremor in 8 studies
4-iodo-2,5-dimethoxyphenylisopropylamine: RN given refers to unlabeled parent cpd without isomeric designation; a serotonin agonist
2-(4-iodo-2,5-dimethoxyphenyl)-1-methylethylamine : An organoiodine compound that is amphetamine bearing two methoxy substituents at positions 2 and 5 as well as an iodo substituent at position 4.
Excerpt | Relevance | Reference |
---|---|---|
"We previously demonstrated that nicotine elicited kinetic tremor by elevating the neural activity of the inferior olive via α7 nicotinic acetylcholine (nACh) receptors." | 7.85 | Serotonergic modulation of nicotine-induced kinetic tremor in mice. ( Iha, HA; Kunisawa, N; Matsubara, N; Nomura, Y; Ohno, Y; Onishi, M; Shimizu, S, 2017) |
"We previously demonstrated that nicotine elicited kinetic tremor by elevating the neural activity of the inferior olive via α7 nicotinic acetylcholine (nACh) receptors." | 3.85 | Serotonergic modulation of nicotine-induced kinetic tremor in mice. ( Iha, HA; Kunisawa, N; Matsubara, N; Nomura, Y; Ohno, Y; Onishi, M; Shimizu, S, 2017) |
" The effect of chronic ACTH treatment on 5-HT(2) receptor and 5-HT(2A)-receptor mRNA levels was not altered by the chronic administration of imipramine." | 1.35 | Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex. ( Akiyama, K; Fujitani, Y; Gomita, Y; Kanzaki, H; Kawasaki, H; Kimoto, S; Kitagawa, K; Kitamura, Y; Ouchida, M; Sendo, T; Shibata, K; Shimizu, K, 2008) |
" (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), a 5-HT2 receptor agonist, induced wet-dog shakes, but not hyperthermia and this response was increased 24 h after the chronic administration of CORT." | 1.30 | Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats. ( Kitamura, Y; Nagatani, T; Takao, K; Yamawaki, S, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 4 (50.00) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kunisawa, N | 1 |
Iha, HA | 1 |
Nomura, Y | 1 |
Onishi, M | 1 |
Matsubara, N | 1 |
Shimizu, S | 1 |
Ohno, Y | 1 |
Marek, GJ | 2 |
Kitamura, Y | 3 |
Kitagawa, K | 2 |
Fujitani, Y | 2 |
Shibata, K | 2 |
Araki, H | 1 |
Sendou, T | 1 |
Gomita, Y | 2 |
Zhang, C | 1 |
Akiyama, K | 1 |
Kimoto, S | 1 |
Kanzaki, H | 1 |
Ouchida, M | 1 |
Shimizu, K | 1 |
Kawasaki, H | 1 |
Sendo, T | 1 |
Baudrie, V | 1 |
De Vry, J | 1 |
Broqua, P | 1 |
Schmidt, B | 1 |
Chaouloff, F | 1 |
Glaser, T | 1 |
Takao, K | 1 |
Nagatani, T | 1 |
Yamawaki, S | 1 |
Mokler, DJ | 1 |
Sullivan, SA | 1 |
Winterson, BJ | 1 |
8 other studies available for 4-iodo-2,5-dimethoxyphenylisopropylamine and Action Tremor
Article | Year |
---|---|
Serotonergic modulation of nicotine-induced kinetic tremor in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Fenclonine; Humans; Male; Mice; Nicot | 2017 |
Behavioral evidence for mu-opioid and 5-HT2A receptor interactions.
Topics: Amphetamines; Animals; Behavior, Animal; Binding, Competitive; Buprenorphine; Cinnamates; Male; Morp | 2003 |
The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenocorticotropic Hormone; Amphetamines; Animals; Body Tem | 2007 |
AMPA receptor involvement in 5-hydroxytryptamine2A receptor-mediated pre-frontal cortical excitatory synaptic currents and DOI-induced head shakes.
Topics: Amphetamines; Analysis of Variance; Animals; Behavior, Animal; Disease Models, Animal; Drug Interact | 2008 |
Increased DOI-induced wet-dog shakes in adrenocorticotropic hormone-treated rats are not affected by chronic imipramine treatment: possible involvement of enhanced 5-HT(2A)-receptor expression in the frontal cortex.
Topics: Adrenocorticotropic Hormone; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Binding Sites; | 2008 |
Subchronic treatment with anxiolytic doses of the 5-HT1A receptor agonist ipsapirone does not affect 5-HT2 receptor sensitivity in the rat.
Topics: Administration, Oral; Amphetamines; Animals; Anti-Anxiety Agents; Blood Glucose; Body Weight; Cortic | 1993 |
Effects of corticosterone on 5-HT1A and 5-HT2 receptor binding and on the receptor-mediated behavioral responses of rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Anti-Inflammatory Agents; Behavior, A | 1997 |
Behaviors induced by 5-hydroxytryptophan in neonatal, preweaning, postweaning, and adult Sprague-Dawley rats.
Topics: 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aging; Amphetamines; Animals; Animals, | 1992 |